Andour L, Kroep JR, Putter H, Tollenaar RAEM, et al. Neoadjuvant endocrine therapy often leads to breast and axilla-conserving surgery in stages II and III hormone receptor-positive breast cancer patients: A registry study. Int J Cancer 2025 Nov 4. doi: 10.1002/ijc.70219.
PMID: 41186970